Global Paradise System US Post Approval Study
NCT: NCT06297291 · RECRUITING
Brief Summary
The objective of the Global Paradise® System US Post Approval Study (US GPS) is to evaluate the real-world use of the Paradise Ultrasound Renal Denervation System indicated for patients who are unable to lower their blood pressure with lifestyle changes and medication. This system is comprised of a catheter, cable, balloon, and generator and has received FDA approval in the United States. Information collected in this study will be analyzed to better understand the long-term safety and effectiveness of treatment with the Paradise System for patients with high blood pressure.
Frequently Asked Questions
What is Global Paradise System US Post Approval Study?
Global Paradise System US Post Approval Study is a clinical trial registered under NCT06297291. Current status: RECRUITING.
What is the status of NCT06297291?
The current status of NCT06297291 (Global Paradise System US Post Approval Study) is: RECRUITING.
When did Global Paradise System US Post Approval Study start?
Global Paradise System US Post Approval Study started on 2024-06-28.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.